Tags

Type your tag names separated by a space and hit enter

Bis(hydrosulfido)-bridged dinuclear rhodium(I) complexes as a platform for the synthesis of trinuclear sulfido aggregates with the core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru).
Dalton Trans. 2013 Mar 14; 42(10):3471-81.DT

Abstract

The reaction of [Rh(μ-SH)(CO)(PPh(3))](2) or [Rh(μ-SH){P(OPh)(3)}(2)](2) with [Cp*MCl(2)](2) (M = Rh, Ir) in the presence of NEt(3) afforded the Rh(3) and IrRh(2) sulfido-bridged compounds [Cp*M(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (M = Rh, 1; Ir, 2) and [Cp*Rh(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (3). The reaction with [MCl(2)(cod)] (M = Pd, Pt), cis-[PtCl(2)(PPh(3))(2)] or [(η(6)-C(6)H(6))RuCl(2)](2) under the same experimental conditions gave [(cod)M(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (M = Pd, 6; Pt, 7), [(cod)M(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (M = Pd, 8; Pt, 9), [(PPh(3))(2)Pt(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (10) and [(η(6)-C(6)H(6))Ru(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (12), with PdRh(2), PtRh(2) and RuRh(2) trimetallic cores. The aggregates derived from [Rh(μ-SH)(CO)(PPh(3))](2) were isolated as a mixture of trans and cis isomers in which the trans isomer predominates. The reaction of [Rh(μ-SH){P(OPh)(3)}(2)](2) with 2 equiv. of n-BuLi at 253 K followed by addition of [Cp*IrCl(2)](2) gave [Cp*Ir(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (4) and [Cp*(2)ClIr(2)(μ(3)-S)(2)Rh{P(OPh)(3)}(2)] (5) in a 3 : 2 ratio. The RuRh(2) compound [(η(6)-C(6)H(6))Ru(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (11) was prepared similarly from [Rh(μ-SH){P(OPh)(3)}(2)](2) and [(η(6)-C(6)H(6))RuCl(2)](2) using n-BuLi as a deprotonating agent. The molecular structures of compounds 3, 6, 7, 9 and 11 have been determined by X-ray analysis. The trinuclear complexes exhibit an asymmetric triangular metal core with two triply bridging sulfido ligands resulting in a distorted trigonal-bipyramidal M(3)(μ(3)-S)(2) heterometallic metal-sulfur core.

Authors+Show Affiliations

Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, C/Pedro Cerbuna, 12, 50009 Zaragoza, Spain.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

23263564

Citation

Castarlenas, Ricardo, et al. "Bis(hydrosulfido)-bridged Dinuclear rhodium(I) Complexes as a Platform for the Synthesis of Trinuclear Sulfido Aggregates With the Core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru)." Dalton Transactions (Cambridge, England : 2003), vol. 42, no. 10, 2013, pp. 3471-81.
Castarlenas R, Cunchillos C, Gómez-Bautista D, et al. Bis(hydrosulfido)-bridged dinuclear rhodium(I) complexes as a platform for the synthesis of trinuclear sulfido aggregates with the core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru). Dalton Trans. 2013;42(10):3471-81.
Castarlenas, R., Cunchillos, C., Gómez-Bautista, D., Jiménez, M. V., Lahoz, F. J., Miranda, J. R., Oro, L. A., & Pérez-Torrente, J. J. (2013). Bis(hydrosulfido)-bridged dinuclear rhodium(I) complexes as a platform for the synthesis of trinuclear sulfido aggregates with the core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru). Dalton Transactions (Cambridge, England : 2003), 42(10), 3471-81. https://doi.org/10.1039/c2dt32680a
Castarlenas R, et al. Bis(hydrosulfido)-bridged Dinuclear rhodium(I) Complexes as a Platform for the Synthesis of Trinuclear Sulfido Aggregates With the Core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru). Dalton Trans. 2013 Mar 14;42(10):3471-81. PubMed PMID: 23263564.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Bis(hydrosulfido)-bridged dinuclear rhodium(I) complexes as a platform for the synthesis of trinuclear sulfido aggregates with the core [MRh2(μ3-S2)] (M = Rh, Ir, Pd, Pt, Ru). AU - Castarlenas,Ricardo, AU - Cunchillos,Carmen, AU - Gómez-Bautista,Daniel, AU - Jiménez,M Victoria, AU - Lahoz,Fernando J, AU - Miranda,José R, AU - Oro,Luis A, AU - Pérez-Torrente,Jesús J, Y1 - 2012/12/21/ PY - 2012/12/25/entrez PY - 2012/12/25/pubmed PY - 2012/12/25/medline SP - 3471 EP - 81 JF - Dalton transactions (Cambridge, England : 2003) JO - Dalton Trans VL - 42 IS - 10 N2 - The reaction of [Rh(μ-SH)(CO)(PPh(3))](2) or [Rh(μ-SH){P(OPh)(3)}(2)](2) with [Cp*MCl(2)](2) (M = Rh, Ir) in the presence of NEt(3) afforded the Rh(3) and IrRh(2) sulfido-bridged compounds [Cp*M(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (M = Rh, 1; Ir, 2) and [Cp*Rh(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (3). The reaction with [MCl(2)(cod)] (M = Pd, Pt), cis-[PtCl(2)(PPh(3))(2)] or [(η(6)-C(6)H(6))RuCl(2)](2) under the same experimental conditions gave [(cod)M(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (M = Pd, 6; Pt, 7), [(cod)M(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (M = Pd, 8; Pt, 9), [(PPh(3))(2)Pt(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (10) and [(η(6)-C(6)H(6))Ru(μ(3)-S)(2)Rh(2)(CO)(2)(PPh(3))(2)] (12), with PdRh(2), PtRh(2) and RuRh(2) trimetallic cores. The aggregates derived from [Rh(μ-SH)(CO)(PPh(3))](2) were isolated as a mixture of trans and cis isomers in which the trans isomer predominates. The reaction of [Rh(μ-SH){P(OPh)(3)}(2)](2) with 2 equiv. of n-BuLi at 253 K followed by addition of [Cp*IrCl(2)](2) gave [Cp*Ir(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (4) and [Cp*(2)ClIr(2)(μ(3)-S)(2)Rh{P(OPh)(3)}(2)] (5) in a 3 : 2 ratio. The RuRh(2) compound [(η(6)-C(6)H(6))Ru(μ(3)-S)(2)Rh(2){P(OPh)(3)}(4)] (11) was prepared similarly from [Rh(μ-SH){P(OPh)(3)}(2)](2) and [(η(6)-C(6)H(6))RuCl(2)](2) using n-BuLi as a deprotonating agent. The molecular structures of compounds 3, 6, 7, 9 and 11 have been determined by X-ray analysis. The trinuclear complexes exhibit an asymmetric triangular metal core with two triply bridging sulfido ligands resulting in a distorted trigonal-bipyramidal M(3)(μ(3)-S)(2) heterometallic metal-sulfur core. SN - 1477-9234 UR - https://www.unboundmedicine.com/medline/citation/23263564/Bis_hydrosulfido__bridged_dinuclear_rhodium_I__complexes_as_a_platform_for_the_synthesis_of_trinuclear_sulfido_aggregates_with_the_core_[MRh2_μ3_S2_]__M_=_Rh_Ir_Pd_Pt_Ru__ L2 - https://doi.org/10.1039/c2dt32680a DB - PRIME DP - Unbound Medicine ER -